The clinician is also affected by positive feedback resulting from PSA testing and subsequent biopsy; we have previously shown that GPs who detect an asymptomatic prostate cancer via PSA testing were 3-times more likely to PSA test other asymptomatic men [15]. This evidence concerns the gene KLK3 and prostate cancer.